Cyclo-Oxygenase (COX) Inhibitors and Cardiovascular Risk: Are Non-Steroidal Anti-Inflammatory Drugs Really Anti-Inflammatory?

Effects of high- and low-dose aspirin on adaptive immunity and hypertension in the stroke-prone spontaneously hypertensive rat

(2018) Shanzana I. Khan et al.   FASEB JOURNAL

Risk of acute myocardial infarction with real-world NSAIDs depends on dose and timing of exposure

(2017) Michèle Bally et al.   PHARMACOEPIDEMIOLOGY AND DRUG SAFETY

Risk of acute myocardial infarction with NSAIDs in real world use: bayesian meta-analysis of individual patient data

(2017) Michèle Bally et al.   BMJ-British Medical Journal

Risk of acute myocardial infarction with NSAIDs in real world use: bayesian meta-analysis of individual patient data

(2017) Michèle Bally et al.   BMJ-British Medical Journal

Cardiovascular Safety of Celecoxib, Naproxen, or Ibuprofen for Arthritis

(2016) Steven E. Nissen et al.   NEW ENGLAND JOURNAL OF MEDICINE

Non-steroidal anti-inflammatory drugs and risk of heart failure in four European countries: nested case-control study

(2016) Andrea Arfè et al.   BMJ-British Medical Journal

Non-steroidal anti-inflammatory drugs and risk of heart failure in four European countries: nested case-control study

(2016) Andrea Arfè et al.   BMJ-British Medical Journal

Molecular Mechanisms for cAMP-Mediated Immunoregulation in T cells – Role of Anchored Protein Kinase A Signaling Units

(2016) Vanessa L. Wehbi et al.   Frontiers in Immunology

Inflammation, Immunity, and Hypertensive End-Organ Damage

(2015) W. G. McMaster et al.   CIRCULATION RESEARCH

Inhibition of cyclooxygenase-2 in hematopoietic cells results in salt-sensitive hypertension

(2015) Ming-Zhi Zhang et al.   JOURNAL OF CLINICAL INVESTIGATION

Origin of the Y Chromosome Influences Intrarenal Vascular Responsiveness to Angiotensin I and Angiotensin (1-7) in Stroke-Prone Spontaneously Hypertensive Rats

(2014) Amanda K. Sampson et al.   HYPERTENSION

Aspirin-triggered 15-epi-lipoxin A4 predicts cyclooxygenase-2 in the lungs of LPS-treated mice but not in the circulation: implications for a clinical test

(2013) Nicholas S. Kirkby et al.   FASEB JOURNAL

Vascular and upper gastrointestinal effects of non-steroidal anti-inflammatory drugs: meta-analyses of individual participant data from randomised trials

(2013)   LANCET

Prostaglandin I2-IP signalling regulates human Th17 and Treg cell differentiation

(2013) Wenxuan Liu et al.   PROSTAGLANDINS LEUKOTRIENES AND ESSENTIAL FATTY ACIDS

Prostaglandin E2 promotes Th1 differentiation via synergistic amplification of IL-12 signalling by cAMP and PI3-kinase

(2013) Chengcan Yao et al.   Nature Communications

Resistance artery mechanics and composition in angiotensin II-infused mice: effects of cyclooxygenase-1 inhibition

(2011) Agostino Virdis et al.   EUROPEAN HEART JOURNAL

M2 Macrophages Induced by Prostaglandin E2 and IL-6 from Cervical Carcinoma Are Switched to Activated M1 Macrophages by CD4+ Th1 Cells

(2011) M. Heusinkveld et al.   JOURNAL OF IMMUNOLOGY

PGE2 transiently enhances DC expression of CCR7 but inhibits the ability of DCs to produce CCL19 and attract naive T cells

(2010) R. Muthuswamy et al.   BLOOD

Celecoxib, but not rofecoxib or naproxen, attenuates cardiac hypertrophy and fibrosis induced in vitro by angiotensin and aldosterone

(2010) Bing H Wang et al.   CLINICAL AND EXPERIMENTAL PHARMACOLOGY AND PHYSIOLOGY

Endothelium-derived Vasoactive Factors and Hypertension: Possible Roles in Pathogenesis and as Treatment Targets

(2010) Michel Félétou et al.   CURRENT HYPERTENSION REPORTS

Inflammation, Immunity, and Hypertension

(2010) David G. Harrison et al.   HYPERTENSION

Ultraviolet Irradiation of Mice Reduces the Competency of Bone Marrow-Derived CD11c+ Cells via an Indomethacin-Inhibitable Pathway

(2010) R. L. X. Ng et al.   JOURNAL OF IMMUNOLOGY

Thromboxane prostanoid receptor activation impairs endothelial nitric oxide-dependent vasorelaxations: The role of Rho kinase

(2009) Cui Qing Liu et al.   BIOCHEMICAL PHARMACOLOGY

Endothelium-dependent contractions in SHR: a tale of prostanoid TP and IP receptors

(2009) Michel Félétou et al.   BRITISH JOURNAL OF PHARMACOLOGY

Cardiomyocyte cyclooxygenase-2 influences cardiac rhythm and function

(2009) D. Wang et al.   PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA

Aging and prostacyclin responses in aorta and platelets from WKY and SHR rats

(2008) Elodie Gomez et al.   AMERICAN JOURNAL OF PHYSIOLOGY-HEART AND CIRCULATORY PHYSIOLOGY

Prostaglandin E2 synergistically with interleukin-23 favors human Th17 expansion

(2008) C. Chizzolini et al.   BLOOD

Prostaglandin E2 enhances T-cell proliferation by inducing the costimulatory molecules OX40L, CD70, and 4-1BBL on dendritic cells

(2008) P. Krause et al.   BLOOD

Recruitment and Activation of Natural Killer Cells In vitro by a Human Dendritic Cell Vaccine

(2008) K. Gustafsson et al.   CANCER RESEARCH

Acceleration of Cardiovascular Disease by a Dysfunctional Prostacyclin Receptor Mutation

(2008) Eric Arehart et al.   CIRCULATION RESEARCH

Cyclooxygenase-2–Derived Prostaglandin F 2α Mediates Endothelium-Dependent Contractions in the Aortae of Hamsters With Increased Impact During Aging

(2008) Siu Ling Wong et al.   CIRCULATION RESEARCH

Thromboxane A2: Physiology/pathophysiology, cellular signal transduction and pharmacology

(2008) Norimichi Nakahata   PHARMACOLOGY & THERAPEUTICS

Gene expression changes of prostanoid synthases in endothelial cells and prostanoid receptors in vascular smooth muscle cells caused by aging and hypertension

(2007) Eva H. C. Tang et al.   PHYSIOLOGICAL GENOMICS